MergerLinks Header Logo

Announced

Completed

Kühne Holding completed the acquisition of Aenova from BC Partners.

Synopsis

Kühne Holding, a holding company, completed the acquisition of Aenova, a contract drug manufacturer, from BC Partners, a private equity firm. BC Partners will reinvest alongside Kühne Holding and continue to support Aenova as a minority shareholder. Financial terms were not disclosed. "With Kühne Holding, we have a strong partner for the further implementation of our strategy to make Aenova the leading CDMO with flexible capacities and innovative speciality platforms. We will continue to strengthen our competitive advantage in the production of conventional dosage forms while expanding in-demand technology platforms and development services to meet the future needs of our customers and thus provide patients worldwide with our services," Jan Kengelbach, Aenova CEO.

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US